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Objective: To explore the mechanism of Toll-like receptor (TLR4) inhibition in the delay of
formation of atherosclerosis by herb-partition moxibustion.
Method: Seventy-five rabbits were randomly assigned to one of five groups: blank, atheroscle-
rosis (AS) model, direct moxibustion, herb-partition moxibustion, and drug treatment. With
the exception of the blank group, all rabbits were given a high-fat diet in addition to immuno-
logic injury to create the AS model. The experiments were carried out for 16 weeks, at which
time the aorta was removed from each rabbit. Immunohistochemical methods were used to
detect the gray level of the aortic TLR4 to observe the immunologic competence of its anti-
gens. Fluorescent quantitative polymerase chain reaction was used to detect the expression
of TLR4 messenger RNA (mRNA) in the aorta.
Results: The gray-scale value of TLR4 and the TLR4 mRNA expression significantly decreased
(p< 0.05) in the direct moxibustion, herb-partition moxibustion, and drug treatment groups.
Furthermore, the effects of the herb-partition moxibustion and drug treatment were superior
to those of the direct moxibustion.
Conclusion: Herb-partition moxibustion inhibits aortic TLR4 activity and mRNA expression,
showing that herb-partition moxibustion delays the formation of atherosclerosis through the
inhibition of TLR4 expression.1. Introduction
Atherosclerosis (AS) is a type of chronic inflammatory
disease, and atherosclerotic plaques are dynamic,cu-Moxibustion and Tuina, Hunan
acopuncture Instituteprogressive lesions caused by the interaction of lipid pla-
ques and the inflammatory response. Inflammation plays an
important role in the process of the onset, progression, and
ultimate rupture of atherosclerotic plaques. In 2009, it wasUniversity of Chinese Medicine, Changsha, Hunan 410007, China.
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plaques as a biomarker and therapeutic target needs to
take into consideration the changes in the type of tempo-
rary plaques [1]. Currently, the prevention and treatment
of AS is carried out mainly through improving the function
of the vascular endothelium, mitigating the inflammatory
reaction, adjusting lipid metabolism, and promoting the
addition of matrix synthesis and the reduction of plaque
degradation; all of these interventions can increase the
stability of the plaques [2]. After differentiating between
endogenous and exogenous ligands, Toll-like receptor 4
(TLR4) initiates the inflammatory response signaling
pathway and induces the expression of inflammatory
factors, finally generating either protective or injurious
effects. Mounting evidence has indicated that TLR4 plays an
important signal transduction role in the formation and
development of AS. TLR4 might be a new target for therapy
against AS [3].
The results from previous studies by our task force
[4e7] indicated that herb-partition moxibustion not only
has an obvious lipid-lowering effect through regulating the
lipid metabolism in hyperlipidemia (HLP) complicated by
AS but also has a therapeutic and protective effect by
intervening in the inflammatory reaction in the injured
vascular endothelial cells, thereby affecting the formation
of AS. Based on this past work, the current work proposed
to study herb-partition moxibustion using a rabbit model
for HLP complicated by AS as an animal model and
immunohistochemical techniques to investigate the
correlation between the delay of AS formation caused by
herb-partition moxibustion and the TLR4 signaling
pathway.
2. Materials and methods
2.1. Laboratory animals
Seventy-five common New Zealand white big-ear rabbits,
male and female, 1.8e2.2 kg and 3 months old, were
supplied by the Hunan Dongchuang experimental animal
center (Certification number: Medical use of animals
quarantine certificate number 2006-0001). Ordinary feed
was also supplied by the Hunan Dongchuang experimental
animal center. Rabbits were caged separately and reared in
the Hunan University of Traditional Chinese Medicine (TCM)
laboratory animal center at an environmental temperature
(18e20 C) with 50e70% relative humidity.
2.2. Moxibustion materials
Moxa cone: Suzhou East Moxa-floss Factory “Shenjiu 300
Jiu” moxa-cone (Model: East-1 type). Herbal cake compo-
sition and production: According to a fixed ratio, Salviae
Miltiorrhizae Radix (dan shen), Crataegi Fructus (shan zha),
Curcumae Radix (yu jin), Rhei Radix et Rhizoma (da huang),
and Alismatis Rhizoma (ze xie) were selected and ground
into a powder. Before use, the powder was mixed thor-
oughly with aged vinegar (chen cu) to form a paste, which
was pinched into herbal cakes approximately 2e3 mm thick
and 1 0.2 cm in diameter.3. Experimental methods3.1. Animal groups
Seventy-five rabbits were divided randomly into five
groups, with 15 rabbits in each group. The groups were:
A. Blank group (Blank comparison group)
B. Model group (AS model group)
C. Directmoxibustiongroup (ASmodelþ directmoxibustion)
D. Herbal cake moxibustion group (AS modelþ herb-
partition moxibustion)
E. Drug group (AS modelþ atorvastatin tablets)
During the experiment, 25 rabbits died. Of these, 12
died acutely upon injection of cow serum protein, 6 died of
diarrhea, 4 died of mange, and 3 died of pulmonary
infection.3.2. Modeling method
The methods used were feeding and immunologic injury.
Rabbits were fed high-fat forage every day (15% egg yolk
powder, 5% pork fat, 2% cholesterol, 0.5% sodium cholate,
and 77.5% common forage, processed into granule forage
by the Hunan University of TCM laboratory animal center)
and were injected with cow serum protein (125 mg/kg of
body weight) in the ear vein on Day 1, Day 3, and Day 5
(three times total). At the same time, the rabbits were
given a subcutaneous injection of egg albumin (2.5 mg/kg/
time, once every 2 days, five times total). Each rabbit was
fed 30 g/kg/day, and food intake was adjusted according
to changes in weight. The weight was recorded every
Monday.3.3. Experimental group treatment
The blank group was fed common forage in a standard
manner, and there was no intervention. The model group
was fed high-fat forage in a standard manner, and there
was no intervention. The direct moxibustion group was fed
high-fat forage in a standard manner and received direct
moxibustion. The herbal cake moxibustion group was fed
high-fat forage in a standard manner and received herb-
partition moxibustion. The drug group was generally fed
high-fat forage in the standard manner and received ator-
vastatin calcium tablets (1 mg/kg/day) in the high-fat
forage.3.4. Acupoint locations and moxibustion methods3.4.1. Acupoint locations
Group I: RN14 (Juque), ST25 (Tianshu) and ST40 (Fenglong).
Group II: BL15 (Xinshu), BL18 (Ganshu) and BL20 (Pishu).
The locations of these points were defined in 1993 by the
World Health Organization, Regional Office for the Western
Pacific, Manila, Philippines.
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Direct moxibustion: On the first day after inspection and
shaving of the specific sites, we gave moxibustion treat-
ment to the rabbits in the appropriate groups. The selected
acupuncture points were first located on the rabbits, and
then the surrounding site was shaved. A 0.5-cm moxa-cone
(a 3-mm-thick, 1-cm-diameter paper saucer was between
the moxa-cone and the site) was pasted onto the acupoints,
and the cones were then lit to start the moxibustion
therapy. Once one moxa-cone had burned up and the local
heat subsided, it was changed to a fresh cone. Every acu-
point received three Zhuang (cones) in succession for
approximately 15e20 minutes each once per day. The
acupoints of Group I and Group II were alternated every day
for a total of 16 continuous weeks.
Herb-partition moxibustion: The acupoint sites were
shaved after the acupoints were located. The medicinal
cakes were pasted onto the acupoints with the moxa-
cone applied directly onto the drug cake, and then the
cone was lit. As with direct moxibustion group, the
points were alternated between Group I and Group II
every other day.
3.5. Specimen collection
3.5.1. Immunohistochemical specimen collection and
treatment
After euthanizing the rabbit subjects, the length of the
aorta between the aorta base and abdominal site where it
bifurcates was quickly removed. A segment of 2 cm in
length was taken from the site, which was 2.5 cm away
from its base, and was cut open vertically and set in a 4%
paraformaldehyde solution.
3.5.2. Fluorescent quantitative polymerase chain
reaction specimen collection and treatment
After euthanizing the rabbit subjects, the length of the
aorta between the aortic base to the aortic arch was
quickly removed. A segment of 1.5 cm in length was washed
with aseptic phosphate-buffered saline (PBS, containing 1%
Diethylpyrocarbonate (DEPC)) and then immediately cry-
opreserved in liquid nitrogen.
3.6. Target detection
Immunohistochemical image acquisition and analysis
(Detection unit: fundamental experimental teaching
center, Hunan University of TCM).
The aorta sample was coated with paraffin and made
into a 5-mm-thick slice. Manipulation was as per the kit
instructions: (1) Conventional dewaxed slides were
hydrated by washing twice with pure xylene lasting 15
minutes each; subjected to alcohol hydration with
a gradient of 100%, 95%, 80%, every 5 minutes; washed for
5 minutes under running water; and washed with distilled
water twice 5 minutes each. (2) Slides were exposed to
a mixture of 1 part 30% H2O2þ 10 parts distilled water at
room temperature for 10 minutes to inactivate endoge-
nous fermentation, followed by washing with distilled
water three times. (3) Hot Fix antigen: the slides were
placed into 0.01 M citrate buffer (pH 6.0), the power wasturned off during boiling in a microwave oven, and these
steps were repeated twice after 5-minute intervals. After
cooling, the samples were washed twice with PBS (pH
7.2). (4) The samples were incubated in a 5% Bovine Serum
Albumin confining liquid for 20 minutes at room temper-
ature. Surplus liquid was removed. (5) The samples were
incubated in the appropriate diluted primary antigens and
rabbit TLR4 monoclonal antibodies (1:100) for 1 hour at
37 C and then washed for 3 2 minutes with PBS (pH
7.2). (6) The samples were incubated with biotinidase
goat anti-rabbit serum IgG for 20 minutes in a 37 C
incubator and then washed for 3 2 minutes with PBS
(pH 7.2). (7) The samples were incubated with Strept
Avidin-Biotin Complex (SABC) for 20 minutes at 37C and
then washed for 4 5 minutes with PBS (pH 7.2). (8)
Diaminobenzidine (DAB) coloration was performed using
a DAB coloration kit. One drop each of the A, B, and C
reagents from the kit was added to 1 mL distilled water,
mixed, and placed on the slides. The color development
occurred at room temperature, and the reaction time was
controlled by the microscope settings before washing with
pure xylene. (9) The slight counterstaining was performed
using hematoxylin and eosin. The samples were dehy-
drated using gradient alcohol, cleared with xylene, and
mounted with neutral gummi. In the negative control
group, PBS was used instead of the primary antigens, but
the other steps were unchanged.
All specimens were viewed at the same magnification in
themedical image analysis system. Each specimen consisted
of one slice that was counted under one field of vision, and
the expression of the antigens was determined by the gray
coloring and the threshold of the positive cells at the
observation site. The extent of gradation was determined
throughout the picture depth, and as the gray threshold was
higher, the tint of positive products was lighter. Each sample
was examined three times and recorded.
3.6.1. Fluorescent quantitative polymerase chain
reaction detection (Detection unit: Hao Yang
bio-technology products Co., ltd., Tianjin, China)
(1) Overall RNA extraction from tissues
From each aorta tissue, a 100-mg sample was taken and
kept under e80 C. They were then placed into a mortar
and pulverized after the addition of liquid nitrogen. Next,
1 mL of Trizol (Hao Yang biotechnology products Co., ltd.,
Tianjin, China) was added immediately, and the samples
were exposed to thermal agitation for 1 minute, followed
by the addition of 200 mL chloroform and another thermal
agitation. After mixing, the samples were placed on ice for
10 minutes and centrifuged at 12,000 rpm for 15 min at
4 C. The upper stratum of water was carefully removed
and placed into a 1.5-mL centrifuge tube, and 800 mL of
isopropyl alcohol was added. After mixing, the samples
rested for 30 minutes at e20C and then were centrifuged
at 12,000 rpm for 10 minutes at 4 C. The supernatants
were discarded, and 1 mL 80% alcohol was added to clean
the precipitates. The samples were centrifuged at
12,000 rpm for 10 minutes at 4 C, the supernatants were
discarded, and the pellets were air-dried for 20 minutes at
room temperature. Then, 20 mL 1% sterilized DEPC water
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stored at e20 C.
(2) RNA density detection
From each RNA sample, 2 mL was added to 198 mL 1%
sterilized DEPC water. The mass and density of the RNA in
each extract sample was determined by ultraviolet spec-
trophotometry, and the A260/A280 ratios were calculated.
(3) Synthesis of complementary DNA
A total of 1 mg of each RNA sample was used, to which
was added 40 mL 1% sterilized DEPC water, 2 mL Oligo(dT)18
(50 pmol/mL), and the samples were incubated in a 70 C
water bath for 5 minutes. The samples were placed on ice
for 2 minutes, and 8 mL 5 reverse transcriptase (RT)-
buffer, 4 mL 10 mM deoxyribonucleotide triphosphate
(dNTPs), 0.5 mL Ribonuclease Inhibitor (RNasin) (40 U/mL),
and 1 mL Moloney Murine Leukemia Virus (M-MLV) reverse
transcriptase (200 U/mL) were added. Next, the samples
were incubated for 1 hour at 42 C. The resulting comple-
mentary DNA was used for polymerase chain reaction (PCR)
amplification.
(4) Primer design and synthesis
The TLR4 and internal reference glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) primers were all
synthesized by Health Industry Co., Ltd., Shanghai, China.
TLR4 (amplification product size: 180 base pairs)
TLR4 upstream primer: 50 - TTT CCA GAA CTT AAC ACA
CCA-30
TLR4 downstream primer: 50-ATG TTC CAG TTG TTC TAA
GCC-30
GAPDH (amplification product size: 174 base pairs)
GAPDH upstream primer 50-GAA CGG GAA GCT GGT CAT
CAA-30
GAPDH downstream primer 50-ATG ATG ACC CTT TTG GCT
CCG-30
(5) Fluorescent quantitative PCR amplification conditions,
determination and detection
Amplification reaction conditions: Predenaturation for 5
minutes at 94 C; denaturation for 30 seconds at 94 C,
annealing and extension for 30 seconds under 59 C, 35
cycles total; final extension for 8 minutes at 72 C.
Detection reaction conditions: Predenaturation for 15
minutes at 95 C; denaturation for 20 seconds at 94 C,
annealing and extension for 20 seconds at 59 C, 60 cycles
total.
3.7. Statistical method
The SPSS 15.0 statistical package (SPSS Inc., Chicago, IL,
USA) was used. The measured data were demonstrated by
the mean and standard deviation (x  s). We first used the
normality and homogeneity tests to check for variance; if
the one-factor analysis of variance normality test indicated
that the group comparison variance was simultaneous, thenwe used least significant difference (LSD) methods; if not,
we used the Tamhane T2 method.
4. Results and analysis
4.1. The effect of herb-partition moxibustion on
TLR4 antigen activity in AS rabbit aorta
The immunohistochemical results showed that the
expression of TLR4 antigens was weak in the control group,
as indicated by a positive tint that was not obvious
(Fig. 1A). The positive expression of TLR4 antigens was
significantly improved in the model group. There was also
an obvious brown-dyed background and grainy material
(Fig. 1B). The expression of the TLR4 antigen in the herb-
partition moxibustion group was obviously weaker than in
the model group. In comparison with the model group, the
gray value of the herb-partition moxibustion group showed
an obvious improvement, and the difference was statisti-
cally significant (p< 0.01) (Fig. 1C). The gray values of the
direct moxibustion group (Fig. 1D) and the drug group
(Fig. 1E) were significantly different compared with the
model group (p< 0.01). The difference in the gray value
between the direct moxibustion group and the herb-
partition moxibustion group was statistically significant
(p< 0.01). The results of the statistical analyses are shown
in Fig. 1.
Table 1 shows the following results:
(1) The gray values of the model group and the direct
moxibustion group were significantly lower than that of
the control group. This shows that the expression of
TLR4 in aorta endothelial cells was higher in these two
groups.
(2) The gray values of the direct moxibustion group, the
herb-partition moxibustion group, and the drug group
were significantly higher (p< 0.01) than that of the
model group. This shows that these three therapeutic
methods have an effect to lower the expression of TLR4
in AS rabbits.
(3) The gray values of the herb-partition moxibustion group
and the drug group were significantly higher (p< 0.01
or p< 0.05, respectively) than that of the direct mox-
ibustion group.
4.2. The influence of herb-partition moxibustion
on the expression of TLR4 mRNA in AS rabbits
Table 2 shows the following results:
(1) The levels of TLR4 mRNA in the aortas of the AS rabbits
in the model group were significantly higher (p< 0.01)
than that in the control group, indicating that the
expression of TLR4 mRNA in the aorta tissue in the
model group increased.
(2) The levels of TLR4 messenger RNA in the aortas of the
AS rabbits in the direct moxibustion group, the herb-
partition moxibustion group and the drug group
decreased significantly (p< 0.01) compared with that
of the model group, indicating that these three
Figure 1 Results of statistical analyses. (A) Blank group,  400. (B) Model group,  400. (C) Herb-partition moxibustion,  400.
(D) Direct moxibustion group,  400. (E) Drug group,  400.
Table 1 The effect of herb-partition moxibustion on the
expression of TLR4 in rabbits with atherosclerosis (x s).
Group n Gray value
Blank group 10 195.610 31.986
Model group 10 122.850 14.927*
Direct moxibustion group 10 157.530 11.481*y
Herbal cake moxibustion group 10 184.990 19.090yx
Drug group 10 178.380 17.538yz
* p< 0.01 compared with the blank group; y p< 0.01 compared
with the model group; z p< 0.05; x p< 0.01 compared with the
direct moxibustion group.
Table 2 The effect of herbal cake moxibustion on TLR4
mRNA expression in rabbits with atherosclerosis (x s).
Group n TLR4 messenger RNA,
relative amount
Blank group 10 2.001 0.802
Model group 10 14.607 2.279*
Direct moxibustion group 10 5.928 0.963*y
Herb-partition
moxibustion group
10 3.523 0.883*yz
Drug group 10 2.882 0.733yz
* p< 0.01 compared with the control group; y p< 0.01
compared with the model group; zp< 0.01 compared with the
direct moxibustion group.
76 Z.-H. Yue et al.
Herb-partition moxibustion 77treatments (direct moxibustion, herb-partition mox-
ibustion and drug) lowered the relative amount of TLR4
mRNA.
(3) The amounts of TLR4 mRNA in the herb-partition mox-
ibustion group and the drug group were significantly
lower (p< 0.01) than that of the direct moxibustion
group.5. Discussion
TLR4 is a very important factor for regulating immune
function. The overactivation of TLR4 leads to abnormalities
in the immune system, in turn leading to multiple diseases.
There is some evidence to suggest that TLR4 is involved
in various processes contributing to the onset of AS, its
progression, and the rupture of plaques. TLR4 can affect AS
in multiple ways. During the early stages of AS, the immune
system accumulates mononuclear cells and T lymphocytes
at the vessel walls, macrophages and a few contractile fiber
cells accumulate under the endothelium, and lipids deposit
in exterior and interior cells. Edfeldt et al. [8] found that
compared with normal vessels, the expression of TLR4 in AS
vessel endothelial cells is increased. Endothelial cells from
human blood vessels cultured in vitro expressed TLR4 at
low levels under normal conditions; however, TLR4 reached
high levels when exposed to inflammatory factor stimula-
tion. The study [9] confirmed that TLR4 excited and
hyperregulated the expression of lectin-like oxidized low-
density lipoprotein receptor-1 (LOX-1) and increased the
adhesion function of endothelial cells. At the same time, it
aggravated and thus caused injury to the endothelial cells.
TLR4 is the receptor of lipopolysaccharide (LPS), which
activates the signal for transduction. Through the activa-
tion of intracellular signaling pathways, LPS finally leads to
the activation of nuclear factors, such as nuclear factor-
kappa B (NF-kB), activator protein-1 [10], and others. LPS
then induces inflammation and also upregulates intercel-
lular adhesion molecule-1, vascular cell adhesion molecule-
1 (VCAM-1), and monocyte chemoattractant protein-1 and
is involved in the accumulation of mononuclear cells. Upon
the addition of a TLR4-blocking agent to mononuclear cells
cultivated in vitro, LPS is blocked, thereby activating the
extracellular signal-regulated kinase (ERK1/2) signaling
pathway in mononuclear cells to prevent their migration
under the endothelium as a deterrent to the formation of
AS [11].
In addition, oxidative stress can also cause a functional
disorder of the endothelium and the adhesion of molecule
expression through TLR4 pathways. With an animal model
of endotoxin injury, it was found that Ox-low density lipo-
protein (ox-LDL) can upregulate the TLR4 level of capillary
vessel endothelial cells and cardiac muscle cells [12],
activate the TLR4 in the macrophages and cause pinocytosis
of oxidative lipid, and finally develop into foam cells and
advance the formation of AS. At the same time, TLR4 can
recognize the oxidative phosphatides in the endothelial
cells and cause the excretion of chemotactic factors such
as interleukin-8 (IL-8). These data demonstrate that
oxidative stress begins its advanced inflammatory reaction
through TLR4. The activation of the TLR4 signaling pathway
may be the important initiator to cause AS.During the aggressive phase of AS, the inflammatory
reaction continues and the formation of fibrous tissue
(mainly collagen) causes changes in the structure of the
arterial tunica intima, inducing AS progression and the
formation of atheromatous plaques. LPS induces elastin
catabolic enzymes to degrade elastin, thereby promoting
smooth muscle cell migration via the TLR4 pathways. Some
experiments have confirmed that the effect of TLR4 on
blood vessel smooth muscle cells is via the action of ox-LDL:
as the density of ox-LDL is increased, the increase of TLR4
mRNA is more apparent [13].
Some research has speculated that in atheromatous
plaques, the higher density of ox-LDL encourages increasing
inflammatory effects, such as TLR4 activity, in the lesions,
thus making the inflammatory lesions of the AS plaques
progress more rapidly. The research found that the acti-
vation of tunica externa fibroblasts by TLR4 could lead to
the formation of neointima, thus suggesting that TLR4
participates in the formation of neointima in AS. After
treatment with TLR4 ligands, the AS area increased in
a mouse model of AS, which indicates that the activation of
TLR4 could encourage the progression of the plaques. At
the same time, research on TLR4 gene polymorphisms has
shown that the severity of cardiovascular diseases may be
related to TLR4 gene polymorphisms to a certain extent
because interleukin-6, fibrinogen, and soluble VCAM-1,
which can lead to the progression of AS, the rupture of
the plaques, and the related inflammatory reaction of
angiemphraxis, are excreted at lower levels in the group
with a TLR4 gene polymorphism. Under stress, human heat
shock proteins (HSP60) can also act as pathogen-associated
molecular patterns and associate with the TLR4 at the
surface of immune cells and activate the proinflammatory
gene that depends on NF-kB, thus stimulating the occur-
rence and the development of AS [14].
TLR is expressed in both normal and scleratheromatic
arteries. We speculate that these receptors may have an
intimate relationshipwith atherosclerosis. Edfeldt et al. [15]
found that TLR4 may be a bridge between bacterial infec-
tions and AS inflammation. Vink et al. [16] found that the
agitation of TLR4 could promote the formation of a tunica
intima that was full of smooth muscle; this smooth muscle
enhancement in the tunica intima was the basis of athero-
sclerotic plaque progression. O’Neill et al. [17] found that
oxidative stress was the main inducer of endothelial cell
injuries and adhesion molecule expression. Oxidized low-
density lipoprotein and oxidative phosphatides affected
the expression and signal transduction pathway of TLR4.
Oxidized low-density lipoprotein increased the expression of
TLR4. Oxidative phosphatides (ox-PAPC) induced the tran-
scription of IL-8 via TLR4. Oxidative stress may aggravate
arteriosclerosis inflammation and immune reactivity through
TLR4. Wald et al. [18] found that TLR4 expression increased
in the macrophages and endothelial cells of human athero-
sclerotic plaques, and that oxidized low-density lipoprotein
could increase the expression of TLR4 in macrophages
cultivated in vitro; this finding indicated that TLR4 exerts
a function in the lipid-mediated proinflammatory response.
Fukao and Koyasu [19] found that the inflammatory reactions
in the atherosclerotic mechanism not only occurred in the
lumen of blood vessel linings but also in the scleratheroma
tunica adventitia of arteries. In the AS coronary artery tunica
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tunica externa also expressed TLR4.
Yilmaz et al. [20] and Thallinger et al. [21] used ator-
vastatin and RNA interference (RNAi) techniques against
AS. The results showed that atorvastatin and RNAi may
decrease the release of inflammatory factors, thereby
reducing the expression of VCAM-1 through inhibition of the
inflammatory signaling pathway of TLR4. Compared with
the atorvastatin group, the RNAi group inhibited the
expression of proteins in the TLR4 signaling pathway and
dramatically decreased the release of inflammatory
factors. However, the difference in the expression of
adhesion molecules between the atorvastatin group and
the RNAi group was not statistically significant. It is possible
that atorvastatin has an effect on lipid regulation. It may
prevent the process of AS through ameliorating lipid
metabolism, reinforcing oxidative stability, protecting the
functioning of endothelial cells, and reducing the expres-
sion of apolipoprotein E (apoE) in the brachiocephalic
arterial walls of mice.
Our study detected the expression of TLR4 in rabbit
aortas by immunohistochemical and fluorescent quantita-
tive PCR techniques. The results showed that the expres-
sion of TLR4 in the aorta of the model group increased
significantly, which indicated that AS occurred and that its
development was closely related to TLR4. We also showed
that the TLR4 expression in the direct moxibustion group,
the herb-partition moxibustion group, and the drug group
decreased as compared with the model group, and that the
accommodation of the herb-partition moxibustion group
and the drug group was better than that of the direct
moxibustion group, which indicated that these three
treatments (direct moxibustion, herbal cake moxibustion,
and drug) had a decreasing effect on the expression of TLR4
in the aorta and delayed the progress of AS. In addition, the
therapeutic effect of the herb-partition moxibustion was
better than that of direct moxibustion but was similar to
the drug.
The herb-partition moxibustion treatment belongs to
the category of indirect moxibustion. It is the pasting or
applying of a drug cake mixture onto selected points. When
the moxa-cone is added on top of the cake and lit, the
thermal effects induce the active components of the
medicine and allow them to penetrate through the skin and
into the acupoints. The physical agent burned in the moxa-
cone and the medicinal chemical compounds in the drug
cake combine with the special role of the acupoints and
the special meridian pathway to obtain a “combined
effect,” which serves the function of dredging the merid-
ians, harmonizing the QI-blood, and conditioning the
organs. The meridians and acupoints respond to the effect
of the herbal ingredients and the stimulating effect of the
moxa; both are indispensable. Based on the TCM theory
that the heart dominates the blood circulation and blood
vessels, the Shu-acupoint and Mu-acupoint of the heart
were selected. These points (RN14 and BL15) are
a compatible match to strengthen heart function, thereby
making the heart QI abundant, the blood strong, and the
flow within the circulatory system smooth and harmonized.
BL18 and BL20 function to aid in preventing the patho-
genesis of AS by tonifying the spleen QI deficiency and
strengthening the liver QI, thereby maintaining a healthyflow of QI within the meridians and blood vessels. The
maintenance of the smooth flow of liver QI and strength-
ening of the spleen QI can also facilitate the conversion of
lipids in the liver. ST40 protects and works against AS
pathogenesis by assisting the removal of phlegm from the
body. The plaque lining the inside of arterial walls is
considered a type of invisible phlegm (according to the
TCM theory), which is metabolized by the spleen system.
ST25 dredges the intestines and balances bodily fluids to
facilitate the absorption of grains (food) and the elimina-
tion of debris in the intestines.
In addition, we selected five traditional Chinese medic-
inal herbs that have the effect of activating blood circula-
tion, removing blood stasis and pain, clearing away heart
fire and removing irritability, nourishing the blood, and
calming the mind. The medicinal herbs used were Salviae
Miltiorrhizae Radix (dan shen), Crataegi Fructus (shan zha),
Curcumae Radix (yu jin), Rhei Radix et Rhizoma (da huang),
and Alismatis Rhizoma (ze xie). These herbs were ground
and formed into small cakes. Modern scientific research has
shown that these medicinal herbs function to be antith-
rombic, decompressive, and cardiotonic; ameliorate the
microcirculation of the liver; dilate blood vessels; resist
arrhythmia; reduce blood fat; and protect the liver. Our
results supply important experimental evidence for the
reasonable clinical application for the treatment of AS
using herb-partition moxibustion and improve the clinical
effectiveness that moxibustion has on its own. Our data
also further promote the safe and effective clinical usage of
moxibustion, thereby allowing more people to intervene in
the occurrence and development of AS. It is our goal to
improve the level of health and quality of living of patients.
In doing so, this research contributes to the future pros-
pects and science of clinical research and applications.
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